ieso
ieso is a Cambridge, UK-based digital mental health company that licenses its Velora conversational AI platform to digital health companies and employers via API or white-label deployment, delivering CBT-based anxiety and depression support built on 750,000+ hours of proprietary therapy data.
- Company typePrivate
- Founded2000
- HeadquartersCambridge, United Kingdom
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What ieso does
ieso is a Cambridge-headquartered digital mental health company that has evolved from a direct therapy provider into an AI platform licensor. Its core product, Velora, is a conversational AI platform that delivers evidence-based cognitive behavioral therapy (CBT) support for symptoms of anxiety and depression, built on a proprietary training corpus of more than 750,000 hours of therapy session data encompassing over 1 billion words accumulated across 20+ years of clinical research and service delivery. The platform integrates into partner care pathways via API or white-label web app, embedding AI-generated therapeutic skills into existing clinical workflows with built-in risk detection and human oversight.
The company operates a B2B enterprise go-to-market model, targeting digital health companies and employers seeking to add scalable mental health capabilities to their platforms without adding clinical headcount. Pricing is quote-based on annual subscription terms. ieso monetizes through platform licensing agreements rather than direct-to-consumer therapy delivery, a model crystallized following the August 2025 divestiture of its NHS-focused subsidiary (ieso Digital Health UK) to Sweden's Mindler. Post-divestiture, ieso's parent entity retains its US-incorporated subsidiary (ieso Digital Health Inc., headquartered in Boston) and a research alliance network spanning ten universities plus Roche and NHS Dorset.
ieso reports having 51-100 employees and $78 million in cumulative disclosed funding, with the most recent round a $53 million Series B led by Morningside with participation from Sony Innovation Fund in November 2021. Leadership is anchored by CEO Nigel Pitchford, Executive Chair Dave Icke, Chairman Andy Richards, CFO Michael Black, and Group Chief Science & Strategy Officer Andy Blackwell, with dedicated EVP roles for Clinical, Impact, and Finance & Commercial functions. The company claims 3:1 ROI across populations supported by Velora, citing reductions in ER visits, improved medication adherence, and lower behavioral health episode costs.
ieso firmographics
Firmographics- Name
- ieso
- Legal name
- ieso Digital Health Inc.
- Website
- https://iesogroup.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- ieso is a Cambridge, UK-based digital mental health company that licenses its Velora conversational AI platform to digital health companies and employers via API or white-label deployment, delivering CBT-based anxiety and depression support built on 750,000+ hours of proprietary therapy data.
- Ownership category
- akta.pro rank
ieso industry classification
Industry- Product category
- Digital Mental Health Software
- NAICS
- Outpatient Mental Health and Substance Abuse Centers (621420), Offices of Mental Health Practitioners (except Physicians) (621330)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
Keywords
Where ieso is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
ieso business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Platform Licensing / API Access: ieso licenses its Velora platform technology to digital health companies through API integration or white-label deployment. The model supports digital health companies seeking to embed mental health support into their care pathways.
- US Market Expansion: Following 2025 expansion of Velora AI platform across the United States, ieso is targeting the large US mental health market to generate revenue through platform licensing agreements with US digital health companies and employers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise platform licensing |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
ieso product offering
Product offeringCore offering
ieso develops and licenses Velora, an AI-powered digital therapeutic platform that delivers evidence-based cognitive behavioral therapy (CBT) support for people experiencing symptoms of anxiety and depression. Velora is distributed via API or white-label web app to digital health companies and employers, embedding CBT-based mental health support directly into existing clinical workflows and care pathways.
Product overview
ieso operates as a mental health technology company offering a single core product platform called Velora. Velora is an AI-powered digital therapeutic program specifically designed for anxiety and depression support. The platform delivers evidence-based CBT skills through conversational AI, integrating seamlessly into digital health companies' existing care pathways via API or white-label web app. Velora represents ieso's complete product portfolio, focused on reducing costs and improving outcomes for digital health companies and employers.
Differentiator
Problem solved
Functional benefit
Brands
- Velora: Evidence-based AI-powered mental health support program for people with symptoms of anxiety and depression, integrating into clinical workflows via API or white-label web app to deliver personalized mental health support.
Products and services
- Velora Velora is an evidence-based AI-powered mental health program that supports people with symptoms of anxiety and depression. It integrates via API or white-label web app into clinical workflows to deliver personalized, clinically validated CBT-based skills, reducing avoidable utilization, improving medication adherence, and increasing engagement among chronic and behavioral health cohorts. It is designed for digital health companies and employers seeking to embed mental health support into their platforms or benefits.
Quantifiable outcome
- 3:1 ROI across supported populations
- +4 more outcomes
Companies that use ieso
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
ieso technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature1 record
ieso partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered flagship and core.
- MindlerflagshipMindler acquired ieso Digital Health UK, the NHS-focused arm of Cambridge-based ieso. The acquisition combines Mindler's pan-European digital therapy platform with ieso's video and text-based CBT services. ieso Digital Health UK retains its UK managing director and operates under the Mindler brand, while ieso's parent company continues independently focusing on AI-powered mental health products.
- RochecoreResearch collaboration partner. ieso collaborates with Roche to study and publish findings that advance the mental health field through evidence-based research.
- University of OxfordcoreResearch collaboration partner for advancing mental health through academic research and clinical validation studies.
- University of CambridgecoreHome institution of ieso's origin; ongoing research collaboration for clinical research and evidence development in digital mental health.
- King's College LondoncoreAcademic research partner collaborating on studies and publications advancing the digital mental health field.
- Imperial College LondoncoreAcademic research partner contributing to evidence base for AI-powered mental health solutions.
- The University of ManchestercoreResearch collaboration partner for digital mental health evidence development.
- University of EdinburghcoreAcademic partner for research and clinical validation in mental health technology.
- The University of SheffieldcoreResearch collaboration partner advancing mental health through academic partnerships.
- Queen Mary University of LondoncoreAcademic research partner in digital mental health studies and publications.
- Memorial UniversitycoreAcademic partner contributing to research in mental health technology and evidence development.
- NHS DorsetcoreClinical partner providing real-world care delivery context for research and validation of digital mental health solutions.
Scale indicators5 records
Recent moves7 records
Expansion highlights5 records
ieso competitors and assessment
Company assessmentDirect peers
- Woebot Health: Woebot Health builds AI-powered conversational mental health tools for anxiety and depression, serving health plans and employers via B2B channels. Directly comparable to ieso's Velora in product category (AI CBT for behavioral health), target buyers (payers/employers), and evidence-based positioning.
- Wysa: Wysa offers an AI-chatbot-based mental health support product sold B2B to employers and health plans. Comparable to Velora as an AI-driven, text-based CBT-style platform for anxiety/depression distributed via enterprise channels.
- Limbic: Limbic is a UK-based AI mental health platform with NHS traction, offering AI triage and self-help tools integrated into IAPT pathways. Closely comparable to ieso in geography (UK roots), NHS heritage, evidence-based AI positioning, and B2B distribution to health systems.
- Akili Interactive: Akili Interactive is a prescription digital therapeutic company with FDA-cleared products for cognitive and behavioral health conditions. Comparable to ieso in the digital therapeutics (DTx/SaMD) category for behavioral health, though Akili focuses on ADHD rather than anxiety/depression.
- Big Health: Big Health produces digital therapeutic products (e.g., Sleepio, Daylight) for insomnia and anxiety, distributed via employers and health plans. Comparable to ieso in digital therapeutics category, behavioral health indication (anxiety), and enterprise channel.
Broad incumbents
- Spring Health: Spring Health is a large, well-capitalized mental health benefits platform serving employers, combining provider networks with digital tools. Comparable to ieso as a competing enterprise buyer target for digital mental health spend, though Spring offers a much broader product portfolio beyond AI CBT.
- Lyra Health: Lyra Health is a large employer-focused mental health benefits provider combining live therapy, coaching, and digital self-serve tools. Comparable as an enterprise mental health competitor for the same employer buyer, though its breadth and provider-network model differ from ieso's pure-AI offering.
- Headspace Health: Headspace Health (the combined Headspace/Ginger entity) is a scaled digital mental health platform selling to employers, payers, and consumers. Comparable to ieso as an enterprise digital mental health competitor, with overlapping employer buyers and broader consumer brand reach.
- Talkspace: Talkspace provides online therapy and psychiatric services to enterprises, health plans, and consumers. Comparable to ieso in serving enterprise mental health buyers and addressing anxiety/depression, though Talkspace is clinician-led rather than AI-first.
Emerging players
- Mindler: Mindler is a Swedish digital therapy provider that acquired ieso Digital Health UK in August 2025. Directly relevant as the acquirer of ieso's legacy NHS arm and a near-clone in digital CBT delivery to health systems across Europe.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
ieso social profiles
Digital presenceieso financial estimates
Financial estimateRevenue estimate
Valuation estimate
ieso leadership team
Management profileNumber of profiles
Profiles10 records
ieso funding detail
Funding detailFunding overview
Funding rounds6 records
Investors11 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ieso M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ieso
What does ieso do?
ieso develops and licenses Velora, an AI-powered digital therapeutic platform that delivers evidence-based cognitive behavioral therapy (CBT) support for people experiencing symptoms of anxiety and depression. Velora is distributed via API or white-label web app to digital health companies and employers, embedding CBT-based mental health support directly into existing clinical workflows and care pathways.
Is ieso a public or private company?
ieso is a private company. It is classified as venture growth investor backed and is currently operating.
When was ieso founded?
ieso was founded in 2000. It employs 51 to 100 people.
Where is ieso based?
ieso is headquartered in Cambridge, United Kingdom, in the Europe region.
How does ieso make money?
Two revenue lines are on record. Platform Licensing / API Access are the primary driver. The others are US Market Expansion.
Who are ieso's main competitors?
Direct peers on record are Woebot Health, Wysa, Limbic, Akili Interactive and Big Health. Broad incumbents are Spring Health, Lyra Health, Headspace Health and Talkspace. Mindler is listed as an emerging player.
Does ieso have an API?
Yes. ieso offers an API that integrates into existing care platforms and clinical workflows to deliver Velora's AI-powered mental health support. The API enables digital health companies to embed clinically validated CBT-based skills into their care pathways. White-label web app integration is also available.
What industry is ieso in?
ieso's product category is Digital Mental Health Software. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital). Its NAICS code is 621420 and its SIC code is 8000.